Pacira Pharmaceuticals Inc (PCRX)
Fixed asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 636,266 | 626,907 | 541,533 | 429,647 | 421,026 |
| Property, plant and equipment | US$ in thousands | 173,927 | 183,512 | 188,401 | 136,688 | 104,681 |
| Fixed asset turnover | 3.66 | 3.42 | 2.87 | 3.14 | 4.02 |
December 31, 2023 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $636,266K ÷ $173,927K
= 3.66
Fixed asset turnover measures the efficiency with which Pacira BioSciences Inc generates revenue from its investment in fixed assets. The trend indicates an increasing ratio from 2019 to 2020, which then drops in 2021 before rising again in 2022 and 2023. This suggests that the company was able to generate more revenue per dollar invested in fixed assets in 2023 compared to previous years, indicating improved asset utilization efficiency. However, the ratio fluctuates over the years, indicating potential variability in the company's operational efficiency in utilizing its fixed assets. It is essential for Pacira BioSciences Inc to continue monitoring and managing its fixed asset turnover to ensure optimal utilization of its fixed asset base.
Peer comparison
Dec 31, 2023